Acrivon Therapeutics Inc. (ACRV) Social Stream



Acrivon Therapeutics Inc. (ACRV): $8.46

0.01 (-0.12%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ACRV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#176 of 359

in industry

ACRIVON THERAPEUTICS INC (ACRV) Price Targets From Analysts

Use the tables below to see what analysts covering ACRIVON THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-12-12 3 $25 $17 $21 $4.98 321.69%
2023-03-29 3 $26 $17 $21.5 $4.98 331.73%
2023-04-20 4 $26 $17 $22.333 $4.98 348.45%
2023-05-09 5 $26 $17 $22.25 $4.98 346.79%
2023-05-10 6 $26 $17 $21.5 $4.98 331.73%
2023-06-02 7 $26 $17 $22.2 $4.98 345.78%
2023-08-14 7 $26 $17 $22.666 $4.98 355.14%
2023-09-06 8 $26 $17 $22.5 $4.98 351.81%
2023-11-09 8 $26 $17 $22.714 $4.98 356.1%
2023-11-10 8 $26 $17 $22.571 $4.98 353.23%
2023-11-15 8 $26 $17 $22 $4.98 341.77%
2023-12-15 8 $26 $12 $21.285 $4.98 327.41%
NA 3 $NA $NA $NA $4.98 NA%

The Trend in the Analyst Price Target


Over the past 12 months, ACRV's average price target has gone up $0.29.

Over the past 37 weeks, ACRV's average upside potential has been 163.94%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-29 3 26 17 21.500 12.71 69.16%
2023-06-02 7 26 17 22.666 12.37 83.23%
2023-09-06 7 26 17 22.500 11.90 89.08%
2023-10-13 8 26 17 22.714 6.06 274.82%
2023-11-09 8 26 17 22.714 4.59 394.86%

ACRV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 8 0 0 0 0 8

The Trend in the Broker Recommendations


ACRV's average broker recommendation rating improved by 0 over the prior 52 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ACRIVON THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1476.78% of all US stocks.
  • ACRV has a greater number of analysts covering the stock than 1515.33% of stocks in the micro market cap category.
  • ACRV has a higher average analyst price target than 1299.56% of stocks in the micro market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ACRIVON THERAPEUTICS INC's variance in analysts' estimates is lower than -314.26% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ACRIVON THERAPEUTICS INC are COYA, SMFL, and XTLB.

Is ACRV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!